[1]张青林,张旭.干细胞治疗青光眼的研究进展[J].眼科新进展,2017,37(9):886-889.[doi:10.13389/j.cnki.rao.2017.0225]
　ZHANG Qing-Lin,ZHANG Xu.Stem cells for the treatment of glaucoma[J].Recent Advances in Ophthalmology,2017,37(9):886-889.[doi:10.13389/j.cnki.rao.2017.0225]
点击复制

干细胞治疗青光眼的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年9期
页码:
886-889
栏目:
文献综述
出版日期:
2017-09-05

文章信息/Info

Title:
Stem cells for the treatment of glaucoma
作者:
张青林; 张旭
330006　江西省南昌市，南昌大学附属眼科医院，江西省眼科学和视觉科学研究所，江西省眼科学重点实验室
Author(s):
ZHANG Qing-Lin; ZHANG Xu
Affiliated Eye Hospital of Nanchang University，Jiangxi Research Institute of Ophthalmology & Visual Sciences，Key Laboratory of Ophthalmology of Jiangxi Province，Nanchang 330006，Jiangxi Province，China
关键词:
青光眼; 干细胞; 视网膜神经节细胞; 小梁网
Keywords:
glaucoma; stem cells; retinal ganglion cells; trabecular meshwork
分类号:
R775
DOI:
10.13389/j.cnki.rao.2017.0225
文献标志码:
A
摘要:
青光眼是一类不可逆性视神经变性和视野缺损的疾病，青光眼导致视神经损伤的机制目前尚未明确，临床上对青光眼的治疗一直未取得良好的效果。干细胞具有自我增殖和分化的能力。近年来随着对干细胞研究的深入，人类利用干细胞治疗青光眼成为可能。青光眼干细胞移植分两大类：一是基于小梁网的干细胞替代治疗，另一类是视网膜神经节细胞的替代治疗。本文就干细胞治疗青光眼的研究进展进行综述。
Abstract:
Glaucoma is a kind of disease with irreversible degeneration of optic nerve and visual field defects，and the mechanism of optic nerve injury caused by glaucoma has undefined at present；meanwhile，the treatment of glaucoma has not been achieving satisfying outcomes in clinical practices.It has been well known that stem cells have the ability to self-proliferate and differentiate.Recently，with the deepening of stem cell research，it is possible for humans to use stem cells to treat glaucoma.There are two methods of stem cell transplantation for glaucoma：stem cell replacement therapy for trabecular meshwork and retinal ganglion cell replacement therapy，so this article will give a review on the progress of stem cells in the treatment of glaucoma.

参考文献/References:

［1］　SUN Y，WILLIAMS A，WAISBOURD M，IACOVITTI L，KATZ LJ.Stem cell therapy for glaucoma：science or snake oil［J］?Surv Ophthalmol，2015，60（2）：93-105.
［2］　PLANT GW，HARVEY AR，LEAVER SG，LEE SV.Olfactory ensheathing glia：repairing injury to the mammalian visual system［J］.Exp Neurol，2011，229（1）：99-108.
［3］　GOEL M，PICCIANI RG，LEE RK，BHATTACHARYA SK.Aqueous humor dynamics：a review［J］.Open Ophthalmol J，2010，4（1）：52-59.
［4］　MATSUMOTO Y，JOHNSON DH.Trabecular meshwork phagocytosis in glaucomatous eyes［J］.Ophthalmologica，1997，211（3）：147-152.
［5］　DU Y，ROH DS，MANN MM，FUNDERBURGH ML，FUNDERBURGH JL，SCHUMAN JS.Multipotent stem cells from trabecular meshwork become phagocytic TM cells［J］.Invest Ophthalmol Vis Sci，2012，53（3）：1566-1575.
［6］　DU Y，YUN H，YANG E，SCHUMAN JS.Stem cells from trabecular meshwork home to TM tissue in vivo［J］.Invest Ophthalmol Vis Sci，2013，54（2）：1450-1459.
［7］　YUN H，ZHOU Y，WILLS A，DU Y.Stem cells in the trabecular meshwork for regulating intraocular pressure［J］.J Ocul Pharmacol Ther，2016，32（5）：253-260.
［8］　ROUBEIX C，GODEFROY D，MIAS C，SAPIENZA A，RIANCHO L，DEGARDIN J，et al.Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma［J］.Stem Cell Res Ther，2015，6（1）：177.
［9］　曹明哲，陈舒怡.从胚胎干细胞到视网膜［J］.中华细胞与干细胞杂志（电子版），2014，4（2）：109-115.
CAO MZ，CHEN SY.From embryonic stem cells to retina［J］.Chin J Cell Stem Cell（Electronic Edition），2014，4（2）：109-115.
［10］　MEYER JS，KATZ ML，MARUNIAK JA，KIRK MD.Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors［J］.Stem Cells，2006，24（2）：274-283.
［11］　HAMBRIGHT D，PARK KY，BROOKS M，MCKAY R，SWARO-OP A，NASONKIN IO.Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina［J］.Mol Vis，2012，18：920-936.
［12］　SCHWARTZ SD，REGILLO CD，LAM BL，ELIOTT D，ROSENFELD PJ，GREGORI NZ，et al.Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy：follow-up of two open-label phase 1/2 studies［J］.Lancet，2015，385（9967）：509-516.
［13］　TAKAHASHI K，YAMANAKA S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors［J］.Cell，2006，126（4）：663-676.
［14］　EL HOKAYEM J，CUKIER HN，DYKXHOORN DM.Blood derived induced pluripotent stem cells（iPSCs）：benefits，challenges and the road ahead［J］.J Alzheimers Dis Parkinsonism，2016，6（5）：275.
［15］　WANG X，XIONG K，LIN C，LV L，CHEN J，XU C，et al.New medium used in the differentiation of human pluripotent stem cells to retinal cells is comparable to fetal human eye tissue［J］.Biomaterials，2015，53（1）：40-49.
［16］　PARAMESWARAN S，DRAVID SM，TEOTIA P，KRISHNAMO-ORTHY RR，QIU F，TORIS C，et al.Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy［J］.Stem Cells，2015，33（6）：1743-1758.
［17］　CHEN M，CHEN Q，SUN X，SHEN W，LIU B，ZHONG X，et al.Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts［J］.Invest Ophthalmol Vis Sci，2010，51（11）：5970-5978.
［18］　PARAMESWARAN S，BALASUBRAMANIAN S，BABAI N，QIU F，EUDY JD，THORESON WB，et al.Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors：therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration［J］.Stem Cells，2010，28（4）：695-703.
［19］　BERNARDOS RL，BARTHEL LK，MEYERS JR，RAYMOND PA.Late-stage neuronal progenitors in the retina are radial Müller glia that function as retinal stem cells［J］.J Neurosci，2007，27（26）：7028-7040.
［20］　SONG WT，ZHANG XY，XIA XB.Atoh7 promotes the differentiation of Müller cells-derived retinal stem cells into retinal ganglion cells in a rat model of glaucoma［J］.Exp Biol Med（Maywood），2015，240（5）：682-690.
［21］　BULL ND，LIMB GA，MARTIN KR.Human müller stem cell（MIO-M1） transplantation in a rat model of glaucoma：survival，differentiation，and integration［J］.Invest Ophthalmol Vis Sci，2008，49（8）：3449-3456.
［22］　BECHERS，EASTLAKEK，JAYARAM H，JONESMF，BROWNRA，GJ M，et al.Allogeneic transplantation of Müller-derived retinal g ¨ anglion cells improves retinal function in a FelineModel of ganglion cell depletion［J］.Stem Cells Transl Med，2016，5（1）：192-205.
［23］　SU Z，CHEN J，QIU Y，YUAN Y，ZHU F，ZHU Y，et al.Olfactory ensheathing cells：the primary innate immunocytes in the olfactory pathway to engulf apoptotic olfactory nerve debris［J］.Glia，2013，61（4）：490-503.
［24］　DAI C，KHAW PT，YIN ZQ，LI D，RAISMAN G，LI Y.Olfactory ensheathing cells rescue optic nerve fibers in a rat glaucoma model［J］.Transl Vis Sci Technol，2012，1（2）：3.
［25］　PAUL G，ANISIMOV SV.The secretome of mesenchymal stem cells：potential implications for neuroregeneration［J］.Biochimie，2013，95（12）：2246-2256.
［26］　BULL ND，JOHNSON TV，MARTIN KR.Stem cells for neuroprotection in glaucoma［J］.Prog Brain Res，2008，173（1）：511-519.
［27］　JOHNSON TV，BULL ND，HUNT DP，MARINA N，TOMAREV SI，MARTIN KR.Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma［J］.Invest Ophthalmol Vis Sci，2010，51（4）：2051-2059.
［28］　ZHANG Y，WANG W.Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina［J］.Invest Ophthalmol Vis Sci，2010，51（7）：3742-3748.
［29］　JIANG Y，ZHANG Y，ZHANG L，WANG M，ZHANG X，LI X.Therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice［J］.Int J Mol Sci，2014，15（6）：9372-9385.
［30］　OH W，KIM DS，YANG YS，LEE JK.Immunological properties of umbilical cord blood-derived mesenchymal stromal cells［J］.Cell Immunol，2008，251（2）：116-123.
［31］　CHUNG S，RHO S，KIM G，KIM SR，BAEK KH，KANG M，et al.Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury［J］.Int J Mol Med，2016，37（5）：1170-1180.
［32］　SUN T，MA QH.Repairing neural injuries using human umbilical cord blood［J］.Mol Neurobiol，2013，47（3）：938-945.
［33］　JIN HJ，BAE YK，KIM M，KWON SJ，JEON HB，CHOI SJ，et al.Comparative analysis of human mesenchymal stem cells from bone marrow，adipose tissue，and umbilical cord blood as sources of cell therapy［J］.Int J Mol Sci，2013，14（9）：17986-18001.
［34］　TZAMERET A，SHER I，BELKIN M，TREVES AJ，MEIR A，NAGLER A，et al.Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy［J］.Exp Eye Res，2014，118（1）：135-144.
［35］　SUN J，MANDAI M，KAMAO H，HASHIGUCHI T，SHIKAMURA M，KAWAMATA S，et al.Protective effects of human iPS-Derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice［J］.Stem Cells，2015，33（5）：1543-1553.
［36］　WERT KJ，SKEIE JM，DAVIS RJ，TSANG SH，MAHAJAN VB.Subretinalinjection of gene therapy vectors and stem cells in the perinatal mouse eye［J］.J Vis Exp，2012，（69）：4286-4292.
［37］　YANAI A，HFELI UO，METCALFE AL，SOEMA P，ADDO L，GREGORY-EVANS CY，et al.Focused magnetic stem cell targeting to the retina using superparamagnetic Iron oxide nanoparticles［J］.Cell Transplant，2012，21（6）：1137-1148.
［38］　JOHNSON TV，BULL ND，MARTIN KR.Identification of barriers to retinal engraftment of transplanted stem cells［J］.Invest Ophthalmol Vis Sci，2010，51（2）：960-970.
［39］　RIAZIFAR H，JIA Y，CHEN J，LYNCH G，HUANGT.Chemically induced specification of retinal ganglion cells from human embryonic and inducedpluripotent stem cells［J］.Stem Cells Transl Med，2014，3（1）：424-432.
［40］　SLUCH VM，DAVIS CH，RANGANATHAN V，KERR JM，KRICK K，MARTIN R，et al.Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line［J］.Sci Rep，2015，5（1）：16595.

相似文献/References:

[1]李翔 谢钊 郭红建 谢学军 路雪婧 王毅 王超.补肾活血中药对大鼠慢性高眼压模型外侧膝状体病理改变的影响[J].眼科新进展,2012,32(1):000.
[2]范虹 刘五存 蔡鸿英 赵堪兴.改良二极管激光睫状体光凝术治疗中晚期青光眼[J].眼科新进展,2012,32(4):000.
[3]王建萍 赵燕麟 马勇 朱涛 程燕 车选义 赵桂娥 王柯.噻吗洛尔和布林佐胺联合曲伏前列素治疗原发性开角型青光眼与高眼压患者的临床研究[J].眼科新进展,2012,32(5):000.
[4]彭坤 靳隽 杨玉新 许银霞 王保君 闫义涛 杨华.长期联合应用噻吗洛尔对结膜组织炎性标记物ICAM-1和HLA-DR表达的影响[J].眼科新进展,2012,32(6):000.
[5]马恩普 赵小钊 董良 刘苏冰 曾照年.Healaflow在青光眼小梁切除术中的应用[J].眼科新进展,2012,32(6):000.
[6]王勇 叶应嘉 鲍先议 周龑丽 许荣 彭婷婷 曾志富.同轴微小切口超声乳化吸出术在青光眼滤过术后白内障摘出术中的应用[J].眼科新进展,2012,32(7):000.
[7]李翔 马世勇 李娟 王毅.补肾活血中药对大鼠慢性高眼压模型视神经病理改变的影响[J].眼科新进展,2013,33(2):000.
[8]白东娥 刘伟 季建.抗青光眼药物对青光眼患者泪液胰岛素水平的影响及其与眼表改变的关系[J].眼科新进展,2013,33(6):000.
[9]王娜 刘振山 冯云 陈银银 薛志刚 范国平.角膜内皮细胞体外培养的研究进展[J].眼科新进展,2013,33(6):000.
[10]马英慧 张铁民 齐建平.原发性开角型青光眼与慢性原发性闭角型青光眼视网膜神经纤维层厚度与视野缺损的关系[J].眼科新进展,2013,33(7):000.
[11]王霞,刘瀛,刘旭,等.诱导多功能干细胞在青光眼治疗中的应用研究进展[J].眼科新进展,2017,37(12):1185.[doi:10.13389/j.cnki.rao.2017.0299]
　WANG Xia,LIU Ying,LIU Xu,et al.Recent advances of induced pluripotent stem cells in glaucoma treatment[J].Recent Advances in Ophthalmology,2017,37(9):1185.[doi:10.13389/j.cnki.rao.2017.0299]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81271425、81260148）
更新日期/Last Update: 2017-10-12